SRIDEVI RAJALINGAM

Mrs. SRIDEVI RAJALINGAM


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2025 in Measurement Science Review
Verified
Journal Article
Open access
PDF file
SRSRIDEVI RAJALINGAM
SRIDEVI RAJALINGAM
KMKavitha Maruthai
Kavitha Maruthai
Breast cancer (BC) is the second most common hereditary cancer in women and is most likely to affect women. The high cost of treating BC has made its prevention an important health issue. However, early detection of BC is a time-consuming and difficult task when using mammogram images. This work introduces a novel TRI-BCC model for BC detection using transfer learning-based tri-level classification with histopathological images. Initially, input images undergo a denoising phase using the Adaptive Brightness Contrast Dynamic Histogram Equalization (ABCDE) technique, which removes noisy artifacts to enhance overall image quality. Following this pre-processing step, a data augmentation phase is employed to synthetically expand the training dataset, thereby improving model generalization and robustness against overfitting. The augmented and pre-processed images are subsequently provided as input to the hybrid Golden Eagle-Whale Optimization (GWO) algorithm, for the segmentation of lesions. In the tri-level classification, transfer learning (TL) models: CapsuleNet, EfficientNet, ShuffleNet, GoogleNet, MobileNet and ResNet are employed to categorize images as benign or malignant (Level-I). Benign cases (Level-II) include Adenosis (AS), Phyllodes tumor (PT), Tubular adenoma (TA) and Fibroadenoma (FA), while malignant cases (Level-II) include Papillary (PC), Mucinous (MC), Lobular (LC), and Ductal (DC) carcinoma. Malignant images are processed using a Randomized Decision Tree (RDT) to classify them into different cancer stages (Level-III) for precise diagnosis. Based on experimental analysis, the TRI-BCC model achieves an overall accuracy of 99.06 % for the categorization of BC. The proposed TRI-BCC model improves overall accuracy by 6.11 %, 0.78 %, 2.66 %, and 13.18 % compared to UNet+YOLO, fine-tuned networks, hybrid deep neural network, and Pa-DBN-BC, respectively.

13 November 2025 in Measurement Science Review
Verified
Journal Article
Open access
PDF file
SRSRIDEVI RAJALINGAM
SRIDEVI RAJALINGAM
KMKavitha Maruthai
Kavitha Maruthai
Breast cancer (BC) is the second most common hereditary cancer in women and is most likely to affect women. The high cost of treating BC has made its prevention an important health issue. However, early detection of BC is a time-consuming and difficult task when using mammogram images. This work introduces a novel TRI-BCC model for BC detection using transfer learning-based tri-level classification with histopathological images. Initially, input images undergo a denoising phase using the Adaptive Brightness Contrast Dynamic Histogram Equalization (ABCDE) technique, which removes noisy artifacts to enhance overall image quality. Following this pre-processing step, a data augmentation phase is employed to synthetically expand the training dataset, thereby improving model generalization and robustness against overfitting. The augmented and pre-processed images are subsequently provided as input to the hybrid Golden Eagle-Whale Optimization (GWO) algorithm, for the segmentation of lesions. In the tri-level classification, transfer learning (TL) models: CapsuleNet, EfficientNet, ShuffleNet, GoogleNet, MobileNet and ResNet are employed to categorize images as benign or malignant (Level-I). Benign cases (Level-II) include Adenosis (AS), Phyllodes tumor (PT), Tubular adenoma (TA) and Fibroadenoma (FA), while malignant cases (Level-II) include Papillary (PC), Mucinous (MC), Lobular (LC), and Ductal (DC) carcinoma. Malignant images are processed using a Randomized Decision Tree (RDT) to classify them into different cancer stages (Level-III) for precise diagnosis. Based on experimental analysis, the TRI-BCC model achieves an overall accuracy of 99.06 % for the categorization of BC. The proposed TRI-BCC model improves overall accuracy by 6.11 %, 0.78 %, 2.66 %, and 13.18 % compared to UNet+YOLO, fine-tuned networks, hybrid deep neural network, and Pa-DBN-BC, respectively.

28 October 2026 in Technology and Health Care
Verified
Journal Article
Closed access
SRSRIDEVI RAJALINGAM
SRIDEVI RAJALINGAM
KMKavitha Maruthai
Kavitha Maruthai
Background: Breast cancer remains a major global health concern, and early and accurate detection is critical for improving clinical outcomes. However, variations in lesion characteristics and imaging conditions in Digital Breast Tomosynthesis (DBT) images present substantial challenges for automated breast tumor classification. Objective: This study aims to develop a robust and interpretable deep learning framework, termed RA-BCNet-PReLU, by integrating residual attention mechanisms with Parametric Rectified Linear Unit (PReLU) activation for accurate multi-class breast tumor classification. Methods: The proposed framework employs a structured processing pipeline comprising Min–Max normalization, stratified sampling, and targeted image augmentation for data preprocessing and generalization. Lesion segmentation is performed using a convolutional neural network (CNN), with segmentation further optimized using the Dynamic Hybrid Grey Wolf–Sunflower Optimization (DHGWSFO) algorithm. Subsequently, handcrafted shape, color, and spatial descriptors are integrated with deep features extracted using ResNet-50 to obtain a comprehensive lesion representation. The fused features are then classified using a residual attention-based CNN with PReLU activation. The model was evaluated on a DBT mammography dataset and externally validated on the CBIS-DDSM dataset. Model reliability was assessed using five-fold cross-validation, ANOVA, paired t -tests, and Wilcoxon signed-rank tests, while Grad-CAM was employed to improve model interpretability. Results: The proposed RA-BCNet-PReLU achieved a mean classification accuracy of 96.87% ± 0.42 on the DBT dataset and 98.72% ± 0.35 on the CBIS-DDSM dataset, with corresponding AUC values of 0.967 and 0.981, respectively. Statistical analyses demonstrated the reliability of the obtained results, while Grad-CAM visualizations highlighted clinically relevant regions contributing to the model's predictions. Conclusion: The proposed RA-BCNet-PReLU framework demonstrates high classification performance, robustness, and interpretability across DBT and external mammography datasets. Its integration of optimized lesion segmentation, hybrid feature representation, residual attention, and explainable visualization indicates its potential as an effective computer-aided tool for automated breast cancer detection and clinical decision support.